Exposing the Three-Dimensional Biogeography and Metabolic States of Pathogens in Cystic Fibrosis Sputum via Hydrogel Embedding, Clearing, and rRNA Labeling.
Physiological resistance to antibiotics confounds the treatment of many chronic bacterial infections, motivating researchers to identify novel therapeutic approaches. To do this effectively, an understanding of how microbes survive in vivo is needed. Though much can be inferred from bulk approaches to characterizing complex environments, essential information can be lost if spatial organization is not preserved. Here, we introduce a tissue-clearing technique, termed MiPACT, designed to retain and visualize bacteria with associated proteins and nucleic acids in situ on various spatial scales. By coupling MiPACT with hybridization chain reaction (HCR) to detect rRNA in sputum samples from cystic fibrosis (CF) patients, we demonstrate its ability to survey thousands of bacteria (or bacterial aggregates) over millimeter scales and quantify aggregation of individual species in polymicrobial communities. By analyzing aggregation patterns of four prominent CF pathogens, Staphylococcus aureus, Pseudomonas aeruginosa, Streptococcus sp., and Achromobacter xylosoxidans, we demonstrate a spectrum of aggregation states: from mostly single cells (A. xylosoxidans), to medium-sized clusters (S. aureus), to a mixture of single cells and large aggregates (P. aeruginosa and Streptococcus sp.). Furthermore, MiPACT-HCR revealed an intimate interaction between Streptococcus sp. and specific host cells. Lastly, by comparing standard rRNA fluorescence in situ hybridization signals to those from HCR, we found that different populations of S. aureus and A. xylosoxidans grow slowly overall yet exhibit growth rate heterogeneity over hundreds of microns. These results demonstrate the utility of MiPACT-HCR to directly capture the spatial organization and metabolic activity of bacteria in complex systems, such as human sputum.


OBJECTIVE
The advent of metagenomic and metatranscriptomic analyses has improved our understanding of microbial communities by empowering us to identify bacteria, calculate their abundance, and profile gene expression patterns in complex environments. We are still technologically limited, however, in regards to the many questions that bulk measurements cannot answer, specifically in assessing the spatial organization of microbe-microbe and microbe-host interactions. Here, we demonstrate the power of an enhanced optical clearing method, MiPACT, to survey important aspects of bacterial physiology (aggregation, host interactions, and growth rate), in situ, with preserved spatial information when coupled to rRNA detection by HCR. Our application of MiPACT-HCR to cystic fibrosis patient sputum revealed species-specific aggregation patterns, yet slow growth characterized the vast majority of bacterial cells regardless of their cell type. More broadly, MiPACT, coupled with fluorescent labeling, promises to advance the direct study of microbial communities in diverse environments, including microbial habitats within mammalian systems.
Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, California, USA.
William H
WH
DePas
Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, California, USA.
Ruth
R
Starwalt-Lee
Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, California, USA.
Lindsey
L
Van Sambeek
Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, California, USA.
Sripriya
S
Ravindra Kumar
Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, California, USA viviana@caltech.edu dkn@caltech.edu.
Viviana
V
Gradinaru
Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, California, USA Division of Geological and Planetary Sciences, California Institute of Technology, Pasadena, California, USA Howard Hughes Medical Institute, California Institute of Technology, Pasadena, California, USA viviana@caltech.edu dkn@caltech.edu.
Dianne K
DK
Newman
Med Microbiol Immunol. 2000 Jun;188(4):169-75
10917153
J Microsc. 2006 Dec;224(Pt 3):213-32
17210054
FEMS Microbiol Ecol. 2006 Apr;56(1):79-94
16542407
Proc Natl Acad Sci U S A. 2016 Jan 12;113(2):E110-6
26715741
Cell. 2014 Aug 14;158(4):945-58
25088144
Thorax. 2012 Oct;67(10):853-9
22379071
J Clin Microbiol. 2006 Sep;44(9):3415-7
16954289
Annu Rev Microbiol. 2003;57:677-701
14527295
Development. 2016 Aug 1;143(15):2862-7
27342713
Trends Microbiol. 2013 Sep;21(9):466-74
23827084
J Clin Microbiol. 2000 Feb;38(2):818-25
10655391
J Cyst Fibros. 2015 Jul;14(4):419-30
25814049
PLoS One. 2011;6(11):e27943
22132176
MBio. 2015 Jul 28;6(4):e00767
26220964
ISME J. 2012 Feb;6(2):471-4
21796216
J Gen Microbiol. 1958 Dec;19(3):592-606
13611202
Cell Microbiol. 2009 Jul;11(7):1034-43
19374653
Mol Reprod Dev. 2015 Jul-Aug;82(7-8):518-29
26153368
Microbiology. 2002 Jan;148(Pt 1):257-66
11782518
Nat Rev Genet. 2012 Mar 13;13(4):260-70
22411464
Proc Natl Acad Sci U S A. 2008 Sep 30;105(39):15070-5
18812504
J Clin Microbiol. 2008 Sep;46(9):3097-100
18562589
Proc Natl Acad Sci U S A. 2012 Apr 10;109(15):5809-14
22451929
MBio. 2014 Mar 18;5(2):e00956-13
24643867
J Cyst Fibros. 2013 May;12(3):194-205
23402821
Curr Top Microbiol Immunol. 2008;322:85-105
18453273
Nat Protoc. 2015 Nov;10(11):1860-96
26492141
Proc Natl Acad Sci U S A. 2016 Feb 2;113(5):E597-605
26787849
Appl Environ Microbiol. 1990 Jun;56(6):1919-25
2200342
J Cyst Fibros. 2015 May;14(3):293-304
25881770
J Clin Microbiol. 2004 Nov;42(11):5176-83
15528712
Cell Host Microbe. 2015 Sep 9;18(3):307-19
26299432
Nat Methods. 2012 Jun 28;9(7):676-82
22743772
Cytometry. 1993;14(2):136-43
7679962
J Innate Immun. 2014;6(6):765-79
24862346
Proc Natl Acad Sci U S A. 2004 Oct 26;101(43):15275-8
15492210
Environ Microbiol. 2006 May;8(5):871-84
16623744
Pediatr Pulmonol. 2009 Jun;44(6):547-58
19418571
Nat Rev Microbiol. 2016 Feb;14(2):93-105
26714431
Nature. 2000 Oct 12;407(6805):762-4
11048725
J Clin Microbiol. 2014 Feb;52(2):425-37
24478471
Am J Respir Crit Care Med. 1994 Aug;150(2):448-54
8049828
Infect Immun. 2014 Nov;82(11):4477-86
25114118
Nature. 2013 May 16;497(7449):332-7
23575631
Int J Med Microbiol. 2010 Dec;300(8):520-5
20843740
J Bacteriol. 2008 Apr;190(8):2767-76
18156255
Environ Microbiol. 2015 Jul;17(7):2532-41
25523128
Eur Respir J. 1990 Jan;3(1):19-23
2107097
ACS Nano. 2014 May 27;8(5):4284-94
24712299
Microbiology. 2012 Jul;158(Pt 7):1818-25
22575897
ISME J. 2013 Nov;7(11):2061-8
23823491